Post-liver transplantation medical complications
- PMID: 16807513
Post-liver transplantation medical complications
Abstract
Liver transplantation (LT) is widely accepted as an effective therapeutic modality for a variety of irreversible acute and chronic liver disease. The success of liver transplantation has increased steadily over the last two decades and several advances have been made since the first human liver transplant. This procedure has become routine with an excellent outcome in terms of both quality and length of survival. The results of liver transplantation have improved due to advances in perioperative technique, a better understanding of the course and prognosis of several liver disease, improved immunosuppressive therapy and more effective postoperative care. Nevertheless, improved tools detecting under immunosuppression, new strategies against viral infections(i.e. cytomegalovirus), and new immunosuppressive drugs will probably even prevent further graft dysfunction in the future. However, complications are common in the early and long term period and contribute to significant morbidity and mortality. One of the major challenges facing the transplant community is the increasing metabolic complications that are now affecting quality of life and long-term survival. Thus, knowledge of complications that emerge during follow up period, early and accurate establishment of diagnosis, and prompt institution of appropriate interventions are essential for optimal patient and graft outcome. This review summarizes available data about medical complications of the early and long term follow up.
Similar articles
-
Management of the Liver Transplant Recipient: Approach to Allograft Dysfunction.Med Clin North Am. 2016 May;100(3):477-86. doi: 10.1016/j.mcna.2016.01.001. Epub 2016 Mar 17. Med Clin North Am. 2016. PMID: 27095640 Review.
-
Immunology of liver transplantation: clinical management aspects.Gastroenterologist. 1997 Jun;5(2):137-47. Gastroenterologist. 1997. PMID: 9193931 Review.
-
Late cellular rejection in paediatric liver transplantation: aetiology and outcome.Transplantation. 2002 Jan 15;73(1):80-4. doi: 10.1097/00007890-200201150-00015. Transplantation. 2002. PMID: 11792983
-
Single-agent immunosuppression after liver transplantation: what is possible?Drugs. 2002;62(11):1587-97. doi: 10.2165/00003495-200262110-00002. Drugs. 2002. PMID: 12109922 Review.
-
[Management of post liver transplantation complications].Rinsho Byori. 2000 Nov;48(11):993-1005. Rinsho Byori. 2000. PMID: 11132563 Review. Japanese.
Cited by
-
Approach to the liver transplant early postoperative period: an institutional standpoint.Rev Bras Ter Intensiva. 2019 Oct-Dec;31(4):561-570. doi: 10.5935/0103-507X.20190076. Rev Bras Ter Intensiva. 2019. PMID: 31967233 Free PMC article. Review.
-
Hepatitis B Patients' Adherence to Treatment in Relation to Knowledge, Attitudes, and Practices (KAP) in the West Bank, Palestine, 2022-2023.J Viral Hepat. 2025 Jan;32(1):e14055. doi: 10.1111/jvh.14055. J Viral Hepat. 2025. PMID: 39716784 Free PMC article.
-
Evaluation of medication-related problems in liver transplant recipients with and without an outpatient medication consultation by a clinical pharmacist: a cohort study.Int J Clin Pharm. 2022 Oct;44(5):1114-1122. doi: 10.1007/s11096-022-01423-6. Epub 2022 Sep 13. Int J Clin Pharm. 2022. PMID: 36100818 Free PMC article.
-
Multi-Task Learning for Post-transplant Cause of Death Analysis: A Case Study on Liver Transplant.AMIA Annu Symp Proc. 2024 Jan 11;2023:913-922. eCollection 2023. AMIA Annu Symp Proc. 2024. PMID: 38222347 Free PMC article.
-
Ischemic Cholangiopathy 11 Years after Liver Transplantation from Asymptomatic Chronic Hepatic Artery Thrombosis.ACG Case Rep J. 2018 Oct 24;5:e75. doi: 10.14309/crj.2018.75. eCollection 2018. ACG Case Rep J. 2018. PMID: 30426033 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical